MSD (Pharmaceutical Products.) is Pharmaceuticals in Indonesia that focus on Pharma Indonesia PT business. Founded in 1972. They cover business area such as Organon Pharma Indonesia PT, manufacture, distribution, pharmaceutical product, Primary Care, Vaccines, Oncology, Specialities, Export sale segment, skincare product, antibiotic, allergy medication, cardiovascular product.
1972
( 52 years old in 2024 )
Pharma Indonesia PT
-
Jalan Jend Sudirman Kav 1
Wisma BNI 46, 27th Floor
Jakarta, 10220
Indonesia
Private
Organon Pharma Indonesia PTmanufacturedistributionpharmaceutical productPrimary CareVaccinesOncologySpecialitiesExport sale segmentskincare productantibioticallergy medicationcardiovascular product
* We use standard office opening hours in near MSD (Pharmaceutical Products.)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
MSD (Pharmaceutical Products.) is Pharmaceuticals business from Indonesia that founded in 1972 (52 years old in 2024), MSD (Pharmaceutical Products.) business is focusing on Pharma Indonesia PT.
MSD (Pharmaceutical Products.) headquarter office and corporate office address is located in Jalan Jend Sudirman Kav 1 Wisma BNI 46, 27th Floor Jakarta, 10220 Indonesia.
MSD (Pharmaceutical Products.) was founded in Indonesia.
In 2024, MSD (Pharmaceutical Products.) is currently focus on Pharma Indonesia PT sector.
Above is snippet of Google Trends for "Pharma Indonesia PT" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with MSD (Pharmaceutical Products.), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
